Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses.

Fenutría R, Martinez VG, Simões I, Postigo J, Gil V, Martínez-Florensa M, Sintes J, Naves R, Cashman KS, Alberola-Ila J, Ramos-Casals M, Soldevila G, Raman C, Merino J, Merino R, Engel P, Lozano F.

PLoS One. 2014 Jan 15;9(1):e84895. doi: 10.1371/journal.pone.0084895. eCollection 2014.

PMID:
24454761
[PubMed - in process]
Free PMC Article
2.

T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Tabbekh M, Mokrani-Hammani M, Bismuth G, Mami-Chouaib F.

Oncoimmunology. 2013 Jan 1;2(1):e22841.

PMID:
23483035
[PubMed]
Free PMC Article
3.

Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Alonso-Ramirez R, Loisel S, Buors C, Pers JO, Montero E, Youinou P, Renaudineau Y.

Arthritis. 2010;2010:130646. doi: 10.1155/2010/130646. Epub 2011 Feb 10.

PMID:
22076177
[PubMed]
Free PMC Article
4.

CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.

Oliveira MI, Gonçalves CM, Pinto M, Fabre S, Santos AM, Lee SF, Castro MA, Nunes RJ, Barbosa RR, Parnes JR, Yu C, Davis SJ, Moreira A, Bismuth G, Carmo AM.

Eur J Immunol. 2012 Jan;42(1):195-205. doi: 10.1002/eji.201040528. Epub 2011 Nov 28.

PMID:
21956609
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Berland R, Fiering S, Wortis HH.

J Immunol. 2010 Dec 15;185(12):7537-43. doi: 10.4049/jimmunol.1002173. Epub 2010 Nov 12.

PMID:
21076064
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

CD5 sweetens lymphocyte responses.

Lenz LL.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1303-4. doi: 10.1073/pnas.0812579106. Epub 2009 Jan 27. No abstract available.

PMID:
19174525
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Vera J, Fenutría R, Cañadas O, Figueras M, Mota R, Sarrias MR, Williams DL, Casals C, Yelamos J, Lozano F.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1506-11. doi: 10.1073/pnas.0805846106. Epub 2009 Jan 13.

PMID:
19141631
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Sarrias MR, Farnós M, Mota R, Sánchez-Barbero F, Ibáñez A, Gimferrer I, Vera J, Fenutría R, Casals C, Yélamos J, Lozano F.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11724-9. Epub 2007 Jun 29.

PMID:
17601777
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Hassan NJ, Simmonds SJ, Clarkson NG, Hanrahan S, Puklavec MJ, Bomb M, Barclay AN, Brown MH.

Mol Cell Biol. 2006 Sep;26(17):6727-38. Erratum in: Mol Cell Biol. 2009 Jun;29(12):3452.

PMID:
16914752
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.

Jin P, Wang E, Provenzano M, Deola S, Selleri S, Ren J, Voiculescu S, Stroncek D, Panelli MC, Marincola FM.

J Transl Med. 2006 Jun 28;4:26.

PMID:
16805915
[PubMed]
Free PMC Article
11.

Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential.

Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL.

J Exp Med. 2003 Oct 20;198(8):1201-12.

PMID:
14568979
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk